StockData

Nutex Health Inc. (NUTX) stock

NUTXNasdaqServices-Business Services, NECFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 15/3072% below fair value
$174.51+4.81 (+2.83%)

Close on Nov 17, 2026Market cap $1.20BP/E 6.9Yield –

Nutex Health r&d expenses

Research and development expenses are spending on new products and technology.

Nutex Health's R&D Expenses for the twelve months ending Mar 31, 2022 was $282.91K, down 45.5% year over year. For fiscal 2021 it was $285.88K, down 48.7% from the year before.

Annual r&d expenses

PeriodPeriod endValueChange
FY2021Dec 31, 2021$285.88K-48.7%
FY2020Dec 31, 2020$557.26K-27.5%
FY2019Dec 31, 2019$768.10K+40.9%
FY2018Dec 31, 2018$545.22K–

Quarterly r&d expenses

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q1 FY2022Mar 31, 2022$73.75K-3.9%
Q4 FY2021Dec 31, 2021$77.27K+42.3%
Q3 FY2021Sep 30, 2021$72.27K-2.1%
Q2 FY2021Jun 30, 2021$59.63K-81.0%
Q1 FY2021Mar 31, 2021$76.72K-33.2%
Q4 FY2020Dec 31, 2020$54.30K-72.4%
Q3 FY2020Sep 30, 2020$73.83K-31.5%
Q2 FY2020Jun 30, 2020$314.26K+11.3%
Q1 FY2020Mar 31, 2020$114.88K-36.6%
Q4 FY2019Dec 31, 2019$196.63K–
Q3 FY2019Sep 30, 2019$107.76K–
Q2 FY2019Jun 30, 2019$282.46K–
Q1 FY2019Mar 31, 2019$181.25K–

More Nutex Health figures

See a number that looks wrong?